- Home
- EIX vs IQV Comparison
EIX vs IQV Comparison
Compare EIX & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EIX
- IQV
- Stock Information
- Founded
- EIX 1886
- IQV 1982
- Country
- EIX United States
- IQV United States
- Employees
- EIX N/A
- IQV N/A
- Industry
- EIX Electric Utilities: Central
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- EIX Utilities
- IQV Health Care
- Exchange
- EIX Nasdaq
- IQV Nasdaq
- Market Cap
- EIX 30.2B
- IQV 35.7B
- IPO Year
- EIX N/A
- IQV 2013
- Fundamental
- Price
- EIX $62.71
- IQV $197.47
- Analyst Decision
- EIX Buy
- IQV Strong Buy
- Analyst Count
- EIX 14
- IQV 17
- Target Price
- EIX $82.54
- IQV $255.88
- AVG Volume (30 Days)
- EIX 5.2M
- IQV 1.3M
- Earning Date
- EIX 02-20-2025
- IQV 02-12-2025
- Dividend Yield
- EIX 5.28%
- IQV N/A
- EPS Growth
- EIX 6.63
- IQV 27.98
- EPS
- EIX 3.42
- IQV 7.62
- Revenue
- EIX $17,321,000,000.00
- IQV $15,315,000,000.00
- Revenue This Year
- EIX $7.82
- IQV $3.67
- Revenue Next Year
- EIX $4.34
- IQV $4.53
- P/E Ratio
- EIX $18.35
- IQV $25.90
- Revenue Growth
- EIX 4.04
- IQV 3.10
- 52 Week Low
- EIX $55.27
- IQV $187.62
- 52 Week High
- EIX $88.77
- IQV $261.73
- Technical
- Relative Strength Index (RSI)
- EIX 26.77
- IQV 45.36
- Support Level
- EIX $59.70
- IQV $194.06
- Resistance Level
- EIX $63.90
- IQV $207.72
- Average True Range (ATR)
- EIX 3.26
- IQV 4.74
- MACD
- EIX -1.54
- IQV 0.12
- Stochastic Oscillator
- EIX 28.89
- IQV 27.90
About EIX Edison International
Edison International is the parent company of Southern California Edison, an electric utility that distributes electricity to 5 million customers in a 50,000-square-mile area of Southern California, excluding Los Angeles. Edison Energy owns interests in nonutility businesses that deal in energy-related products and services. In 2014, Edison International sold its wholesale power generation subsidiary Edison Mission Energy out of bankruptcy to NRG Energy.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.